๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Washed Microbiota Transplantation for Clostridioides Difficile Infection
NCT06106698Clostridioides Difficile Infection
The Second Hospital of Nanjing Medical University
Observational
100
Nanjing
2023-07-22
Active, closed
A Phase โ…ก Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC)
NCT06015503NSCLC (Non-small Cell Lung Cancer)
Avistone Biotechnology Co., Ltd.
Phase 2
139
Guangzhou
2023-07-21
Active, closed
Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
NCT05861102Ankylosing Spondylitis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3
265
Shanghai
2023-07-20
Recruiting
A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study
NCT05954429Colorectal Cancer
Fudan University
Phase 2
50
Shanghai
2023-07-20
Recruiting
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
NCT05983107HR+/HER2- Advanced Breast Cancer, Targeted Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
102
Beijing
2023-07-20
Recruiting
Study of VEGF-A Targeting NIR-II Fluorescence Endoscopy in the Gastrointestinal Tract
NCT06430372Gastrointestinal Carcinoma, Dysplasia, Gastrointestinal Polyp
Institute of Automation, Chinese Academy of Sciences
Phase 1
30
Beijing
2023-07-20
Not yet open
A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors
NCT05940116Non-Small Cell Lung Cancer, Solid Tumor
Hansoh BioMedical R&D Company
Phase 1
322
Tianjin
2023-07-20
Recruiting
Registry of X-linked Adrenoleukodystrophy
NCT05939232X-linked Adrenoleukodystrophy
Beijing Tiantan Hospital
Observational
200
Beijing
2023-07-20
Recruiting
Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.
NCT05895981Ulcerative Colitis
Xijing Hospital
Not applicable
15
Xi'an
2023-07-20
Recruiting
DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC
NCT06354231Renal Insufficiency, Upper Urinary Tract Urothelial Carcinoma, Solitary Kidney
Fudan University
Phase 2
20
Shanghai
2023-07-20
Recruiting
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
NCT05756322Relapsed or Resistant Acute Leukaemias
Lin BioScience, Inc
Phase 1/2
90
Xinxiang, Jining, Tianjin
2023-07-20
Active, closed
Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors
NCT06220318Solid Tumor
Fujian Haixi Pharmaceuticals Co., Ltd.
Phase 1/2
155
Xiamen, Changsha
2023-07-19
Recruiting
a Single-arm, Single-center, Open Clinical Study
NCT06431100Gastric Cancer, Esophageal Cancer, Cervical Cancer, Non-Small Cell Lung Cancer NSCLC
Beijing Geekgene Technology Co., LTD
Observational
10
Zhengzhou
2023-07-19
Active, closed
A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT05880706Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
198
Shanghai
2023-07-19
Active, closed
A Study of A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane Therapy
NCT06968585HER2-positive Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 3
365
Shanghai
2023-07-18
By invitation
Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery
NCT06258863Breast Neoplasm Female
Hubei Cancer Hospital
Observational
300
Wuhan
2023-07-18
Recruiting
Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
NCT06126510Sarcoma
CNBG-Virogin Biotech (Shanghai) Ltd.
Phase 2
40
Beijing
2023-07-18
Recruiting
Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
NCT05974904Metabolic Dysfunction-associated Fatty Liver Disease, Hepatic Steatosis, Liver Fibrosis
Chongqing Medical University
Observational
7,000
Chongqing
2023-07-18
Recruiting
A Clinical Study of Hyperthyroidism in Children
NCT06570967Hyperthyroidism
Shengjing Hospital
Observational
1,000
Shenyang
2023-07-18
Active, closed
Effects of Shanyu Pill in Older Adults With Sarcopenia
NCT05919368Sarcopenia
Fujian University of Traditional Chinese Medicine
Not applicable
192
Fuzhou, Guangzhou
2023-07-17
Recruiting
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
NCT05659732Acute Myeloid Leukemia, Lymphoma, Mantle-Cell
PharmaEngine
Phase 1
32
2023-07-17
Recruiting
The PRECISION-T2D Study: Precision Nutrition Study for Type 2 Diabetes
NCT05885828Type 2 Diabetes
Westlake University
Not applicable
200
Hangzhou
2023-07-17
Recruiting
BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
NCT06644443Multiple Myeloma in Relapse
Shenzhen University General Hospital
Phase 1/2
10
Shenzhen
2023-07-15
Recruiting
Software Refraction With Mobilerone Versus Retinoscopy
NCT06059521Myopia, Myopia, Moderate, Astigmatism
Beijing Airdoc Technology Co., Ltd.
Not applicable
120
Beijing
2023-07-15
Not yet open
Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL
NCT05918276CLL/SLL
Nanfang Hospital, Southern Medical University
Phase 2
24
Wuhan, Changsha
2023-07-15
Recruiting
CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma
NCT05948033Lymphoma
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2023-07-15
Active, closed
The Beijing Adult Dry Eye Cohort Study
NCT06621446Dry Eye
Beijing Tongren Hospital
Observational
1,200
Beijing
2023-07-15
Recruiting
CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid Tumors
NCT05947487Solid Tumor, Adult
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2023-07-15
Active, closed
A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
NCT05943795Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
589
Guangzhou, Hangzhou
2023-07-14
Active, closed
AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer
NCT05904379Advanced Non-small-cell Lung Cancer
Akeso
Phase 1/2
233
Hangzhou, Shanghai
2023-07-13
Recruiting
IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC
NCT05994131NSCLC
InxMed (Shanghai) Co., Ltd.
Phase 1/2
110
Shanghai
2023-07-13
Recruiting
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
NCT06684028Cancer, Solid Malignancies
Affiliated Hospital of Jiangnan University
Not applicable
30
Wuxi
2023-07-12
Recruiting
Pulmonary Hypertension Observational Study
NCT05958901Pulmonary Hypertension
The First Affiliated Hospital of Guangzhou Medical University
Observational
10,000
Guangzhou
2023-07-12
Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT05980949Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Zhenjiang, Nanchang
2023-07-11
Recruiting
Surgical Treatment of Irreducible Atlantoaxial Dislocation
NCT05847270Irreducible Atlantoaxial Dislocation
Peking University Third Hospital
Not applicable
70
Beijing
2023-07-11
Recruiting
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
NCT05911217Pancreatic Cancer
CARsgen Therapeutics Co., Ltd.
Phase 1
20
Beijing, Zhengzhou, Wuhan, Changsha, Shanghai, Xian, Hangzhou
2023-07-11
Active, closed
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
NCT05677451Chronic Spontaneous Urticaria
Novartis Pharmaceuticals
Phase 3
100
Guangzhou, Chengdu, Beijing
2023-07-11
Recruiting
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
NCT06005493Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma, Esophageal Adenocarcinoma
AstraZeneca
Phase 1/2
280
Beijing, Shandong
2023-07-11
Recruiting
A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC
NCT07133958Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC)
Zhujiang Hospital
Observational
35
Guangzhou
2023-07-11
Recruiting
The Maintenance Treatment of "ITIVA" in AML Patients
NCT06256627Acute Myeloid Leukemia, Maintenance Treatment, Minor Residue Disease, Interferon-ฮฑ-1b
Henan Cancer Hospital
Not applicable
130
Zhengzhou
2023-07-11
Recruiting
A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations
NCT05886920Advanced Solid Tumors With MAPK Pathway Mutations
D3 Bio (Wuxi) Co., Ltd
Phase 1/2
67
Beijing, Guangzhou, Harbin, Wuhan, Shanghai, Chengdu, Hangzhou
2023-07-10
Active, closed
Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia
NCT05975996Severe Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
43
Tianjin
2023-07-10
Active, closed
A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients
NCT05787613NSCLC Stage IV
Shanghai Henlius Biotech
Phase 2
132
Xuzhou, Shanghai
2023-07-10
Recruiting
Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer
NCT05571644Colorectal Cancer
Sun Yat-sen University
Phase 2
143
Guangzhou
2023-07-10
Active, closed
To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia A
NCT07548411Severe Hemophilia A
Gritgen Therapeutics Co., Ltd.
Phase 1/2
7
Wuhan, Tianjin
2023-07-10
Recruiting
Effects of Preoperative Rehabilitation on Tendon Healing, Bone Mineral Density, and Cartilage After ACLR and Patellar Dislocation
NCT05924178Anterior Cruciate Ligament Rupture
Peking University Third Hospital
Not applicable
60
Beijing
2023-07-10
Active, closed
Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer
NCT05969899Colorectal Cancer
Fudan University
Phase 2
50
Shanghai
2023-07-10
Recruiting
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
NCT06208917Pediatric Solid Tumor, Unspecified, Protocol Specific
Yizhuo Zhang
Phase 3
376
Guangzhou
2023-07-09
Recruiting
Metastatic Nasopharyngeal Carcinoma
NCT06886347Metastatic Nasopharyngeal Carcinoma
Chen Xiaozhong
Phase 1
47
Hangzhou
2023-07-07
Active, closed
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
NCT05957510Small-cell Lung Cancer
Guangdong Association of Clinical Trials
Phase 2
66
Guangzhou
2023-07-07
Recruiting
A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer
NCT06042998Gastric Cancer Stage II, Gastric Cancer Stage III
The Affiliated Hospital of Qingdao University
Not applicable
588
Qingdao
2023-07-07
Recruiting
Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder
NCT05798403Overactive Bladder
Yin Ping
Not applicable
204
Shanghai
2023-07-07
Active, closed
Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).
NCT06175351Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
80
Baotou, Beijing, Changsha, Chengdu, Chongqing, Fuyang, Guangzhou, Hengyang
2023-07-06
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Hefei, Beijing, Foshan, Guangzhou, Shenzhen, Nanning, Guiyang, Wuhan
2023-07-06
Recruiting
Low-dose NOAC Versus GDMT After LAAO
NCT05960721Atrial Fibrillation
Xijing Hospital
Not applicable
4,220
Xi'an
2023-07-06
Recruiting
Cardiovascular Risk Assessment and Dynamic Monitoring-based Prevention Trial
NCT05919056Cardiovascular Diseases
Peking University
Not applicable
22,032
Ningbo
2023-07-06
Recruiting
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
NCT05884255Advanced Gastroenteropancreatic Neuroendocrine Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
220
Shanghai, Tianjin
2023-07-06
Active, closed
CS1-Targeted CAR-T Cells for Relapsed/Refractory Multiple Myeloma
NCT07809594Relapsed/Refractory Multiple Myeloma (RRMM), Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
10
Tianjin
2023-07-05
Recruiting
Prizvalve Proโ„ข Transcatheter Aortic Valve Replacement Study
NCT05864456Aortic Valve Stenosis
Shanghai NewMed Medical Co., Ltd.
Not applicable
73
Shanghai
2023-07-05
Active, closed
Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors
NCT05914376Advanced Solid Tumors
Hangzhou Converd Co., Ltd.
Phase 1
24
Hangzhou, Shanghai
2023-07-05
Recruiting
Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis
NCT06119490Toxic Epidermal Necrolysis
Peng Zhang
Phase EARLY_PHASE1
30
Fuzhou
2023-07-05
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
Taiho Oncology, Inc.
Phase 2
120
Guangzhou, Harbin, Nanjing, Changchun, Jinan, Shanghai, Chengdu, Hangzhou
2023-07-05
Recruiting
A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer
NCT05911958HER2 Low Breast Carcinoma
Henan Cancer Hospital
Phase 2
66
Zhengzhou
2023-07-05
Recruiting
Endocrine Glucose & Lipids Metabolism and Brain Aging: a Longitudinal Study
NCT06066775Brain Aging Related Conditions
Shandong Provincial Hospital
Observational
10,000
Jinan
2023-07-04
Recruiting
Combination of CAR-DC Vaccine and ICIs in Malignant Tumors
NCT05631886Solid Tumor, Adult, Lymphoma, EphA2 Overexpression, TP53 R273H
Chinese PLA General Hospital
Phase 1
10
Beijing
2023-07-04
Active, closed
Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer
NCT05771584Gastric Cancer
Aston Sci. Inc.
Phase 2
24
2023-07-04
Recruiting
To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL
NCT06045091Multiple Myeloma, Plasma Cell Leukemia
Hrain Biotechnology Co., Ltd.
Phase EARLY_PHASE1
18
Shanghai
2023-07-04
Recruiting
The Role of Biomarkers in the Occurrence and Development of Asthma
NCT05768399Asthma in Children
Children's Hospital of Chongqing Medical University
Observational
2
Chongqing
2023-07-04
Recruiting
A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
NCT05991583Advanced Malignant Tumors
SUNHO๏ผˆChina๏ผ‰BioPharmaceutical CO., Ltd.
Phase 1/2
25
Shanghai
2023-07-03
Not yet open
A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure
NCT05875649AML
Nanfang Hospital, Southern Medical University
Observational
137
Guanzhou
2023-07-02
Recruiting
Whole-course Immunonutrition Combined With ChemoradiotherapyยฑICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
NCT05833594Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Immunonutrition, Inoperable
Anhui Provincial Hospital
Observational
70
Hefei
2023-07-01
Not yet open
Atherectomy Followed With a Drug Coated Balloon in the Treatment of Long Femoropopliteal Lesions
NCT05868564Peripheral Arterial Disease
RenJi Hospital
Not applicable
100
Shanghai
2023-07-01
Recruiting
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
NCT06120426Spinal Metastases, Spinal Tumor, Radiotherapy, Malignant Bone Tumor
Shanghai Changzheng Hospital
Observational
182
Shanghai
2023-07-01
Recruiting
PaCIFiC-CUP Classifies Cancer of Unknown Primary
NCT06140992Unknown Primary Tumors, DNA Methylation
Sun Yat-sen University
Observational
120
Guangzhou
2023-07-01
Recruiting
Diagnostic Accuracy of Capnography in Nasogastric Tube Placement
NCT05817864Capnography, Nasogastric Tube, Diagnostic Accuracy
Chinese University of Hong Kong
Observational
390
Hong Kong
2023-07-01
Recruiting
Transvaginal NOSES Versus Conventional Laparoscopic Surgery for Right Hemicolectomy
NCT05495048Colon Cancer
Shanghai Minimally Invasive Surgery Center
Not applicable
356
Shanghai
2023-07-01
By invitation
Establishment of a Predictive System for Perioperative Risk Assessment and Electronic Flowcharting Response Strategies in Thoracic Surgery
NCT06566053Perioperative Complications
Hengxing Liang
Observational
10,000
Changsha
2023-07-01
Recruiting
Pre-pectoral Breast Reconstruction With or Without Mesh
NCT05888571Prepectoral Breast Reconstruction, TiLOOP Mesh
Tianjin Medical University Cancer Institute and Hospital
Not applicable
164
Tianjin
2023-07-01
Recruiting
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
NCT05925504Lower Risk MDS Per IPSS-R
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
36
Tianjin
2023-07-01
Recruiting
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
NCT06287541Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University
Not applicable
428
Nanjing
2023-07-01
Not yet open
A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL
NCT05931757Philadelphia-Positive ALL
The First Affiliated Hospital of Soochow University
Phase 2
22
Suzhou
2023-07-01
Recruiting
Interactions Between Environmental Exposures and Gut Microbiota in Early Life
NCT06479928Infant Development
Peking University People's Hospital
Observational
756
Beijing
2023-07-01
Not yet open
Association of Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric Infarction
NCT05914272Stroke
Nanfang Hospital, Southern Medical University
Observational
2,592
Fuzhou, Dongguan, Guangzhou, Heyuan, Huizhou, Haikou, Changsha, Hengyang
2023-07-01
By invitation
Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma
NCT06076252Ampullary Cancer, Bile Duct Cancer, Pancreas Cancer, Duodenum Cancer
Affiliated Hospital of Guangdong Medical University
Not applicable
150
Zhanjiang
2023-07-01
Recruiting
Non-invasive BCI and Application Verification for Depressed People
NCT06417437Depression, Major Depressive Disorder, Bipolar Depression
Shanghai Mental Health Center
Phase 4
400
Shanghai
2023-07-01
Recruiting
Safety and Preliminary Efficacy of iEVs Injection in Treating Lateral Epicondylitis of Humerus
NCT07111325Lateral Epicondylitis
Shanghai 6th People's Hospital
Phase 1/2
24
Shanghai
2023-07-01
Recruiting
Standardized Nutritional Management of Pediatric Patients With Solid Tumors
NCT06730204Tumor, Solid, Children, Nutritional Intervention
Children's Hospital of Fudan University
Not applicable
400
Shanghai
2023-07-01
Recruiting
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
NCT05925309Biliary Atresia, Cholangitis, Anti-Bacterial Agents
Children's Hospital of Fudan University
Not applicable
356
Shanghai
2023-07-01
Recruiting
Venetoclax Combined With Azactidine in the Treatment of ALAL
NCT05901974Acute Leukemia of Ambiguous Lineage
Sheng-Li Xue, MD
Phase 2
23
Suzhou
2023-07-01
Recruiting
Effects of Lactulose on Gut Microbiota and Metabolism in Diabetic Constipated Patients
NCT07065942Diabetes Mellitus, Constipation - Functional
Peking Union Medical College Hospital
Not applicable
60
Beijing
2023-07-01
Recruiting
Precision Medicine of Diabetes Program in China
NCT06320600Diabetes
Second Xiangya Hospital of Central South University
Observational
120,000
Changsha
2023-07-01
Recruiting
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
NCT05911503Cytomegalovirus Retinitis, Ganciclovir Eye Drops
Tianjin Medical University
Phase EARLY_PHASE1
15
Tianjin
2023-07-01
Recruiting
AI-Agent for Automated Diagnosis and Predicting Using EHR and Multimodal Data
NCT06791499AI Agent
The Eye Hospital of Wenzhou Medical University
Observational
2,000,000
Guangzhou, Chengdu, Wenzhou
2023-07-01
Not yet open
The China CardioMyopathy Registry Study
NCT05871632Cardiomyopathies
China National Center for Cardiovascular Diseases
Observational
5,000
Beijing
2023-07-01
Recruiting
A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal Carcinoma
NCT05940441to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University
Observational
74
Shanghai
2023-07-01
Not yet open
Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma
NCT05909098NK Cell, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory
Xiangyang No.1 People's Hospital
Phase 1/2
33
Hubei
2023-07-01
Recruiting
Study on the Health Economic Burden of Alzheimer's Disease in China
NCT05995418Alzheimer Disease
Xuanwu Hospital, Beijing
Observational
9,510
Beijing
2023-07-01
Active, closed
Smartphone App for Non-alcoholic Fatty Liver Disease
NCT05180760Non-Alcoholic Fatty Liver Disease
The University of Hong Kong
Not applicable
260
Hong Kong
2023-07-01
Active, closed
Fruquintinib Plus Checkpoint Inhibitor Combined or Sequential TAS-102 in Colorectal Cancer Patients Who Progressed on Second-line Standard Therapy: a Prospective, Multi-cohort, Single-centered, Phase Ib/II Study
NCT07491159Colorectal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1/2
106
Tianjin
2023-07-01
Recruiting
A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.
NCT05984537Coronary Microvascular Dysfunction
Peking University First Hospital
Phase 4
70
Beijing
2023-07-01
Rows per page Showing 15001–15100 of 19052
Previous 149 150 151 152 153 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=151

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.